-
Astrazeneca’s Lokelma Receives EU Approval
AstraZeneca is a global, science-led biopharmaceutical company, announced that the European Commission has granted marketing authorisation for Lokelma...
2018-04-04 17:06 -
DCC Completes REACH Registration for Wide Range of Products
Dominion Colour Corporation (DCC) offers a broad color palette of pigments worldwide. To ensure ongoing supply to the European Union (EU), DCC has suc...
2018-04-04 16:57 -
Jiaxing PC Shuts PTA Unit for Turnaround
Pengwei plans to shut the 900kta PTA plant for two-month turnaround at the end of the month.Its upstream PX unit will be shut around Apr 10.
2018-04-04 15:10 -
Solvay Launches New Step in Transformation to Better Serve Customers
Solvay SA is taking a new step in its transformation, putting its customers at the core of its organization to enhance its long-term growth as an adva...
2018-04-02 16:42 -
Shell Wins Four Additional Exploration Blocks in Brazil Deepwater Bid
Shell Brasil Petroleo, a subsidiary of Royal Dutch Shell plc (Shell), has won four additional deep-water exploration blocks in the Campos and Potiguar...
2018-04-02 16:42 -
AkzoNobel to Sell Specialty Chemicals to The Carlyle Group and GIC for €10.1bn
" Werner Fuhrmann, CEO of AkzoNobel Specialty Chemicals, said: "Specialty Chemicals is a strong and profitable business with highly skil...
2018-04-02 16:35 -
Idifarma Expands High Potent Capabilities
Idifarma has launched new GMP spray drying capabilities. The new capabilities will allow the contract development and manufacturing organizations (CDM...
2018-03-30 17:02 -
Actinium, Astellas Form Research Partnership
Actinium Pharmaceuticals has entered into a research and option agreement with Astellas to develop Actinium-225 Radio-Conjugates (ARCs) using its Acti...
2018-03-30 17:02 -
Gyros Protein Technologies Upgrades Services
Gyros Protein Technologies AB, a provider of automated nanoliter-scale immunoassays and peptide synthesizers and reagents, said Oxford BioMedica, a ge...
2018-03-30 16:58 -
Martin Pharmaceuticals Receives FDA Orphan Drug Designation for LIVANTRA™
Martin Pharmaceuticals, a clinical stage pharmaceutical company focused on repurposing already-approved drugs to offer life-changing advances to patie...
2018-03-30 16:50
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
